什么是后生元？燕教授为何押注这一赛道？ 后生元(Postbiotics)是指益生菌经灭活处理后释放的有益代谢物(如短链脂肪酸、细菌素、胞外多糖等)， 具有高稳定性、强安全性、无需冷链、耐胃酸等优势，尤其适合儿童、孕妇及肠胃敏感人群长期使用。 燕教授联合科研团队，精选高活性后生元复合配方，率先应用于口腔护理产品中，有效平衡口腔菌群、 抑制有害菌、修复黏膜屏障，获得用户广泛认可。 如今，这一技术正式迈向"内服"新阶段。燕教授后生元闪释粉采用创新闪释技术，开袋即溶，无需冲 泡，入口3秒快速吸收。产品以高纯度后生元为核心，协同多种植物活性成分，靶向调节肠道微生态， 增强身体防护盾，帮助用户远离"肝"扰，夯实健康根基。 当"益生菌"已成过去式，"后生元"正成为健康新风口。作为国内率先系统布局后生元技术的健康品牌， 广东浠芮生物科技有限责任公司旗下健康管理品牌燕教授不仅推出了广受好评的后生元植萃牙膏等口腔 护理系列，更将这一前沿理念从"口腔微生态"拓展至肠道健康、体重管理与内服抗衰全场景，真正实 现"由口入身"的健康闭环。 而2025年6月重磅上市的全新产品——燕教授后生元闪释粉，正是这一战略的关键落子。 便捷营养补充： ...

（文章来源：证券日报） 证券日报网讯 1月20日，南威软件在互动平台回答投资者提问时表示，蚂蚁集团布局"AI+健康"赛道， 恰恰印证了该领域的巨大市场空间与C端用户需求的确定性。健康管理需求本身具有显著的分层化、场 景化特征，不存在"单一产品通吃"的市场格局；而头部平台的入场，更有助于加速用户健康管理习惯的 培育，进一步做大行业整体市场规模。尽管茶寿健康与部分互联网平台产品在功能表象上存在相似性， 但二者的底层逻辑与生态定位截然不同。互联网大厂依托流量优势，更多聚焦于服务广度的覆盖；茶寿 健康则立足垂直领域，聚焦于服务深度的挖掘。在技术与医疗资源方面，茶寿健康与北京大学医学部共 建联合实验室，整合国内顶级医院专家知识库，构建医生数字分身，具备多维报告深度解读、疾病预测 分析与个性化干预方案生成能力；在场景差异化方面，茶寿健康不仅面向C端用户提供个性化健康管理 服务，更深度赋能B端（企业/保险机构）、H端（医疗机构）及G端（社区公卫体系），构建起"全身 份、全场景"的服务闭环。这种深度整合线下服务资源与专业医疗能力的"重服务"模式，是茶寿健康区 别于其他平台的独特竞争优势。公司坚定看好茶寿健康的发展前景，无终止 ...

Core Viewpoint - The article discusses the rise of medical tourism in China, highlighting the integration of healthcare services with travel experiences, driven by policies like the 240-hour visa-free transit and the "Healthy China 2030" strategy, which aims to make healthcare services more accessible and appealing to international visitors [5][14]. Group 1: Medical Tourism Growth - The implementation of the 240-hour visa-free policy has led to a significant increase in foreign visitors to China, with 40.6 million arrivals in the past year, marking a 27.2% year-on-year growth [5]. - Chinese hospitals, particularly in major cities like Beijing, Shanghai, and Shenzhen, are increasingly catering to international patients, offering competitive pricing and efficient services compared to Western countries [8][13]. - The cost of medical procedures in China is significantly lower than in the U.S.; for example, a heart bypass surgery costs approximately $40,000 in China compared to $130,000 in the U.S. [8]. Group 2: Unique Offerings and Experiences - Chinese hospitals are not only providing medical services but also integrating cultural experiences, such as traditional Chinese medicine, into their offerings, which enhances the appeal for international tourists [15]. - The article highlights successful cases of foreign patients receiving treatment in China, showcasing the effectiveness and affordability of the services provided [7][14]. - The combination of medical treatment and tourism is creating a unique experience that is gaining recognition among international visitors, with some even traveling to China for childbirth [14]. Group 3: Future Projections and Market Potential - The medical tourism market in China is projected to exceed 300 billion yuan by 2029, driven by the dual forces of the "Healthy China" strategy and rising consumer spending [17]. - The article draws parallels with other countries that have successfully developed their medical tourism sectors, such as Cuba and Japan, indicating that China is still in the early stages of establishing a recognizable global brand in this field [18][25]. - The competition among Chinese cities to become the leading destination for medical tourism is intensifying, with initiatives and standards being developed to enhance service quality and attract more international patients [24][23].

Core Insights - The health industry is experiencing unprecedented development opportunities while facing challenges related to industrial transformation and model innovation [1] - "Integration" has become an irreversible trend in the health industry, as noted by industry expert Yang Renshang [1] Industry Trends - The health industry is shifting from a focus on single medical services to comprehensive life-cycle health management [1] - The integration trend is highlighted as a key driver for future growth and innovation within the health sector [1] Business Model Innovation - Yang Renshang emphasizes the importance of commercial model innovation in adapting to the evolving landscape of the health industry [1] - The need for businesses to create synergies and build regional ecosystems is critical for success in the health sector [1]

Core Viewpoint - The strategic cooperation agreement signed among Sichuan Health Promotion Association, Chengdu Jiaozi Health Medical Investment Co., Ltd., and Sichuan Aikang Guobin Health Management Co., Ltd. aims to enhance health services in Sichuan, aligning with the "Healthy China" strategy [1][3][11]. Group 1: Cooperation Framework - The collaboration focuses on creating a new service ecosystem characterized by "public welfare empowerment, industry implementation, and regional health improvement" [3]. - Sichuan Health Promotion Association will play a guiding role, while Chengdu Jiaozi Health Medical Investment Co., Ltd. will leverage local resources to facilitate service delivery [3][8]. - Sichuan Aikang Guobin Health Management Co., Ltd. will provide comprehensive health management services, including health check-ups and chronic disease management [8][21]. Group 2: Key Areas of Focus - The partnership will concentrate on two main areas: health management services and grassroots health public welfare [8]. - The health management services will form a closed loop of "guidance, connection, and execution," ensuring effective project implementation [8]. - In grassroots health public welfare, the association will guide project design, while the investment company will provide logistical support, and Aikang will contribute medical expertise [8][21]. Group 3: Future Directions - The collaboration is seen as a significant opportunity for Sichuan Aikang to deepen regional health services and fulfill social responsibilities [21]. - Aikang plans to establish a special working group to refine cooperation plans, set timelines, and clarify responsibilities to ensure effective implementation [21]. - The company aims to enhance service capabilities and extend public welfare services to more communities, ensuring quality health resources reach the grassroots level [21].

（来源：上观新闻） 在国家全面推进"健康中国2030"战略的背景下，企业如何将自身发展融入国家大局，以创新与韧性应对 经济周期挑战，成为检验其价值与担当的重要标准。海阳集团作为以健康产业为核心、多元协同发展的 现代化企业集团，始终以战略定力锚定方向，以创新实践驱动发展，在服务全民健康的道路上持续展现 韧性，为"健康中国"建设注入企业动能。 一、筑牢发展根基，稳健穿越周期 面对复杂多变的外部环境与市场波动，海阳集团坚持聚焦健康产业，秉持长期主义理念。通过前瞻布局 与稳健经营，集团成功应对多轮经济冲击，实现持续健康发展。从早期深耕核心医疗领域，到逐步延伸 至大健康产业链上下游，海阳集团以科技创新为引擎，以质量安全为底线，不断夯实产业基础。通过优 化资产结构、加强风险管控、保持研发投入，集团构建了更具韧性和成长性的业务生态系统，在周期波 动中稳步前行，为国家健康战略的实施储备了坚实力量。 二、对接国家战略，贡献多维力量 海阳集团积极践行"健康中国"战略，将企业成长与国家需求紧密结合，在多个层面发挥积极作用： 1. 提升医疗服务可及性与品质：集团依托旗下医疗机构与合作网络，持续增强基层医疗服务能力，引入 先进技术与管 ...

Core Insights - The Chinese health consumption market is undergoing a significant transformation, shifting from "wild growth" to "meticulous cultivation," with competition evolving into an ecosystem-based contest [1][2] - The health management market in China is projected to exceed 850 billion yuan in 2024, with a compound annual growth rate of 21.3%, expected to surpass 2.3 trillion yuan by 2030 [2] - The rise of rational consumption, particularly among younger consumers, emphasizes the importance of product transparency and scientific communication [3] Industry Trends - The traditional model of health services is being replaced by a comprehensive health management approach, focusing on the entire lifecycle of health rather than one-time services [4] - Companies are increasingly adopting integrated health solutions that combine products and services, moving away from merely selling individual items [3][4] Company Strategies - Minsheng Health is pursuing a diversified expansion strategy, targeting various segments within the health sector, including nutritional supplements and medical aesthetics [6] - In contrast, Meinian Health is focusing on deep specialization in preventive medicine, establishing a clear brand hierarchy to serve different market segments [6] - Both companies are building health management ecosystems, with Meinian leveraging its extensive health data for AI development and personalized health management [7] - Minsheng Health emphasizes collaboration across the supply chain, particularly in the probiotics sector, to enhance product quality and technological competitiveness [8]

（来源：经济参考报） 当前，全球医疗总开支居高不下，各国医疗负担逐步加重。主动健康作为一种以预防为核心、以个体为 主体的前瞻性健康管理理念与实践模式，成为破除传统医疗困境的重要探索。 德国一项著名的医学研究表明，超过70%的慢性病与生活方式、心理状态以及免疫力息息相关。这些疾 病，如高血压、糖尿病、抑郁症等，往往并不需要完全依赖药物治疗，可以通过改善生活方式、调节心 理压力等方式，让身体自身的修复机制发挥作用。 利用森林等大自然资源进行非医疗手段治疗疾病是典型的主动健康方式。19世纪40年代，德国创立了世 界上第一个森林浴基地，形成了最初的森林康养概念。慕尼黑大学研究证实，每周3次森林漫步可使抑 郁症患者的症状减轻30%。1982年，日本政府将森林浴纳入国家健康计划，指定了100余处"森林疗法基 地"。东京医科大学实验显示，森林浴后受试者血压平均下降5mmHg。 例如，挪威特罗姆瑟利用北极光与海滨环境开发的"极地疗愈"，针对季节性情感障碍，利用负氧离子与 海浪声调节自主神经系统，改善睡眠质量；匈牙利布达佩斯温泉疗养中心将含硫温泉浸泡用于治疗关节 炎和银屑病，结合水下运动促进关节修复；美国密歇根州Green C ...

Core Insights - The strategic partnership between Meinian Health and Aihui Long aims to integrate advanced in vitro diagnostic technology with a vast health examination network and AI health management platform to enhance disease screening efficiency and preventive medicine levels [1][3] Group 1: Strategic Collaboration - The signing ceremony for the strategic cooperation took place in Shanghai, attended by key figures from both companies, indicating a significant milestone for Meinian Health in deepening health service capabilities [3] - The collaboration is expected to enrich Meinian's health examination products with Aihui Long's cutting-edge diagnostic projects in areas such as autoimmune diseases, cardiovascular issues, diabetes, and central nervous system diseases [3][4] Group 2: Health Management Ecosystem - The partnership will focus on four core areas to create a comprehensive health management service system that spans prevention, detection, treatment, and management, aligning with national health management guidelines [4] - Aihui Long will assist Meinian Health in developing tailored autoimmune disease screening packages to identify high-risk individuals early and provide timely interventions [4] Group 3: Disease-Specific Management - The collaboration will establish a comprehensive management system for cardiovascular diseases, integrating prevention, diagnosis, treatment, and management, supported by Aihui Long's precise cardiovascular disease marker detection [5][6] - For diabetes, the partnership will cover the entire risk management chain, from early screening to functional assessment, providing a full-cycle service to mitigate chronic disease impacts [7] Group 4: Neurological Disease Prevention - Aihui Long's advancements in early warning systems for central nervous system diseases, including Alzheimer's, will be integrated with Meinian Health's services to enhance early detection and intervention capabilities [8] - The collaboration aims to shift the paradigm of health management for neurological diseases from passive treatment to proactive health strategies, contributing to the "Healthy China" initiative [8]

Core Insights - The strategic partnership between Meinian Health and Aihuilong aims to integrate advanced in vitro diagnostic technology with a vast health examination network and AI health management platform to enhance disease screening efficiency and preventive medicine levels [1][2] Group 1: Partnership Objectives - The collaboration focuses on building a comprehensive health management service system that spans prevention, diagnosis, treatment, and management, aligning with national health management guidelines [2][3] - Meinian Health's Chairman emphasized that this partnership is a significant milestone in deepening health service capabilities and enhancing professional barriers [2] Group 2: Specific Areas of Focus - Aihuilong will assist Meinian Health in customizing autoimmune disease screening packages tailored to different examination populations, enabling early identification and risk warning for high-risk individuals [3] - The partnership will establish a comprehensive management system for high-risk cardiovascular patients, integrating prevention, diagnosis, treatment, and management into a closed-loop healthcare pathway [3] Group 3: Future Vision - The collaboration aims to create a continuously evolving and collaboratively innovative health management ecosystem that provides proactive health management services across the entire life cycle [4] - This initiative supports the national chronic disease prevention strategy and contributes to the broader "Healthy China" vision through industry innovation [4]